WT1 mutation
|
AML
|
WT1 mutation
|
AML
|
gilteritinib Resistant: B - Late Trials
|
gilteritinib Resistant: B - Late Trials
|
WT1 mutation
|
AML
|
WT1 mutation
|
AML
|
venetoclax Resistant: C3 – Early Trials
|
venetoclax Resistant: C3 – Early Trials
|
WT1 mutation
|
AML
|
WT1 mutation
|
AML
|
TP-0903 Resistant: D – Preclinical
|
TP-0903 Resistant: D – Preclinical
|
WT1 mutation
|
AML
|
WT1 mutation
|
AML
|
sorafenib + GMI-1359 Sensitive: D – Preclinical
|
sorafenib + GMI-1359 Sensitive: D – Preclinical
|